Many researchers are unaware of the legalities when it comes to sharing and using copyrighted material, but licensing agreements can help, says Kate Alzapiedi of copyright licensing firm RightsDirect.
Now that the rapid exchange of scientific research and product information across international borders has become commonplace, rights holders and users of published material face an increasingly complex set of issues involving reuse rights, permissions, restrictions and fees.
Copyright laws vary from one country to the next, making the resulting mix of obligations difficult to reconcile and enforce, especially for global, research-driven organisations with employees working in different countries.
Research and information professionals in the pharmaceutical and life sciences industries depend on the ability to disseminate important information quickly for a variety of reasons—to accelerate drug discovery, to keep physicians and patients informed, to communicate with government regulatory authorities and to monitor the safety of drugs in the pipeline and in the marketplace.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Copyright compliance, RightDirect, research, Outsell
